Is Mankind pharma ready for Wave 2 rally?
Posted decent Quarterly numbers, Revenue up 11% at Rs 2708.1 Cr. EBIDTA up 15% Rs. 682.7 Cr.
Maintaining healthy margin of 25.2%.
The stock has been sideways after wave 1 rally post its listing. The stock did a Fib 0.38 retracement and holding on it Symmetrical triangle formation and breakout above 1829 will open the stock for an upside of 1929 followed by 2120, with a stop of below 1720 long positions can be maintained in the stock.
Maintaining healthy margin of 25.2%.
The stock has been sideways after wave 1 rally post its listing. The stock did a Fib 0.38 retracement and holding on it Symmetrical triangle formation and breakout above 1829 will open the stock for an upside of 1929 followed by 2120, with a stop of below 1720 long positions can be maintained in the stock.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.